Showing 441-460 of 503 for: Cochrane Systematic Reviews > Neurologic 
- Tacrine for Alzheimer's disease
Cochrane Systematic Reviews, 6-Nov-2008
Tacrine is one of the first drugs to be widely marketed for the loss of memory and intellectual decline in Alzheimer's disease, often accompanied by abnormal behaviour and physical decline. The alleged success of tacrine in the treatment of these symptoms
- The effects of anaesthetic agents on cortical mapping during neurosurgical procedures involving eloquent areas of the brain
Cochrane Systematic Reviews, 4-Oct-2011
In patients presenting for surgical resection of lesions involving, or adjacent to, the functionally important eloquent cortical areas, it is vital to achieve complete or near complete resection of the pathology without damaging the healthy surrounding ti
- The Epley (canalith repositioning) manoeuvre for benign paroxysmal positional vertigo
Cochrane Systematic Reviews, 3-Dec-2014
This is an update of a Cochrane Review first published in The Cochrane Library in Issue 1, 2002 and previously updated in 2004 and 2007.
- Therapeutic exercise for people with amyotrophic lateral sclerosis or motor neuron disease
Cochrane Systematic Reviews, 2-Apr-2013
Despite the high incidence of muscle weakness in individuals with amyotrophic lateral sclerosis (ALS) or motor neuron disease (MND), the effects of exercise in this population are not well understood. This is an update of a review first published in 2008.
- Therapeutic interventions for disease progression in Huntington's disease
Cochrane Systematic Reviews, 7-May-2009
Huntington's disease (HD) is an autosomal dominant neurodegenerative disease with an average onset between the fourth and fifth decade of life; it leads to death 15 to 20 years after the onset of symptoms. Although several drugs seem effective in controll
- Therapeutic interventions for symptomatic treatment in Huntington's disease
Cochrane Systematic Reviews, 7-May-2009
Huntington's disease (HD) is an orphan autosomal dominant neurodegenerative disorder caused by the amplification of a nucleic acids triplet repeat. It is characterised by core symptoms of chorea, progressive dementia and psychiatric manifestations such as
- Therapeutic monitoring of antiepileptic drugs for epilepsy
Cochrane Systematic Reviews, 13-Apr-2010
This is an updated version of the original Cochrane review published in Issue 1, 2007.
- Therapies for depression in Parkinson's disease
Cochrane Systematic Reviews, 12-Nov-2008
Depression is one of the most common neuropsychiatric disturbances in Parkinson's disease. 40% of observed variation in quality of life is due to depression. However, there is little hard evidence of the efficacy and safety of antidepressant therapies in
- Thiamine for Alzheimer's disease
Cochrane Systematic Reviews, 5-May-2008
Vitamin B1 (thiamine) deficiency plays an important role in Wernicke-Korsakoff syndrome. This is a form of brain damage occurring in long-term alcoholics who rely mainly on alcohol for nutrition. The acute syndrome (Wernicke's encephalopathy) is normally
- Thioridazine for dementia
Cochrane Systematic Reviews, 12-Apr-2012
Neuroleptic drugs are controversial treatments in dementia, with evidence accumulating that they may hasten clinical decline. Despite these concerns, they are commonly prescribed for elderly and demented patients. Thioridazine, a phenothiazine neuroleptic
- Third generation cephalosporins versus conventional antibiotics for treating acute bacterial meningitis
Cochrane Systematic Reviews, 26-May-2013
Antibiotic therapy for suspected acute bacterial meningitis (ABM) needs to be started immediately, even before the results of cerebrospinal fluid (CSF) culture and antibiotic sensitivity are available. Immediate commencement of effective treatment using t
- Thyroid hormones for preventing neurodevelopmental impairment in preterm infants
Cochrane Systematic Reviews, 17-Feb-2009
Observational studies have shown an association between transiently low thyroid hormone levels in preterm infants in the first weeks of life (transient hypothyroxinemia) and abnormal neurodevelopmental outcome. Thyroid hormone therapy might prevent this m
- Tiagabine add-on for drug-resistant partial epilepsy
Cochrane Systematic Reviews, 4-Feb-2014
Epilepsy is a common neurological condition that affects almost 0.5% to 1% of the population. Nearly 30% of people with epilepsy are resistant to currently available drugs. Tiagabine is one of the newer antiepileptic drugs; its effects as an adjunct (add-
- Timing of hypertonic saline inhalation for cystic fibrosis
Cochrane Systematic Reviews, 13-Apr-2015
Inhalation of hypertonic saline improves sputum rheology, accelerates mucociliary clearance and improves clinical outcomes of people with cystic fibrosis.
- Topical capsaicin (high concentration) for chronic neuropathic pain in adults
Cochrane Systematic Reviews, 18-Feb-2013
Topical creams with capsaicin are used to treat peripheral neuropathic pain. Following application to the skin capsaicin causes enhanced sensitivity, followed by a period with reduced sensitivity and, after repeated applications, persistent desensitisatio
- Topical lidocaine for the treatment of postherpetic neuralgia
Cochrane Systematic Reviews, 28-Oct-2013
This is an update of the original Cochrane review published in Issue 2, 2007. The cause of postherpetic neuralgia is damage to peripheral neurons, dorsal root ganglia, and the dorsal horn of the spinal cord, secondary to herpes zoster infection (shingles)
- Topiramate add-on for drug-resistant partial epilepsy
Cochrane Systematic Reviews, 14-Feb-2014
The majority of people with epilepsy have a good prognosis and their seizures are controlled by a single antiepileptic drug. However, up to 20% of patients from population-based studies and up to 30% from clinical series (not population-based) develop dru
- Traditional Chinese medicine for epilepsy
Cochrane Systematic Reviews, 11-Mar-2014
Seizures are poorly controlled in many people with epilepsy, despite current antiepileptic treatments. Some turn to alternative or complementary therapy to treat their condition and the use of traditional Chinese medicinal herbs (TCMH) is increasingly pop
- Tramadol for neuropathic pain
Cochrane Systematic Reviews, 8-Feb-2009
Peripheral neuropathic pains often include symptoms such as burning or shooting sensations, abnormal sensitivity to normally painless stimuli, or an increased sensitivity to normally painful stimuli. Neuropathic pain is a common symptom in many diseases o
- Transcutaneous electrical nerve stimulation (TENS) for chronic pain
Cochrane Systematic Reviews, 10-Jul-2014
Transcutaneous electrical nerve stimulation (TENS) is a popular pain treatment modality but its effectiveness in chronic pain management is unknown. This review is an update of the original Cochrane review published in Issue 3, 2001.
